1. Home
  2. UZX vs LPCN Comparison

UZX vs LPCN Comparison

Compare UZX & LPCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

UZX

Linkage Global Inc. Class A Ordinary Shares

N/A

Current Price

$1.33

Market Cap

15.8M

ML Signal

N/A

Logo Lipocine Inc.

LPCN

Lipocine Inc.

N/A

Current Price

$2.07

Market Cap

18.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
UZX
LPCN
Founded
2011
1997
Country
Japan
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.8M
18.7M
IPO Year
2023
2011

Fundamental Metrics

Financial Performance
Metric
UZX
LPCN
Price
$1.33
$2.07
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $5.00
AVG Volume (30 Days)
★ 7.3M
31.0K
Earning Date
06-30-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $1,976,677.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$18.02
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.07
$1.81
52 Week High
$1.88
$12.37

Technical Indicators

Market Signals
Indicator
UZX
LPCN
Relative Strength Index (RSI) 66.07 49.10
Support Level $0.14 $2.16
Resistance Level $1.88 $2.27
Average True Range (ATR) 0.10 0.10
MACD 0.07 -0.01
Stochastic Oscillator 69.03 54.79

Price Performance

Historical Comparison
UZX
LPCN

About UZX Linkage Global Inc. Class A Ordinary Shares

Linkage Global Inc is a cross-border e-commerce integrated service provider. It provides international e-commerce merchants, overseas brands, import and export trading enterprises, etc. with a globally selected supply chain, digital marketing, e-commerce training, international store, ERP and e-commerce software, social e-commerce and other e-commerce integrated services. The company has two operating segments: Extend from Japan, and Other Subsidiaries from Hong Kong. The company is Committed to building a one-stop cross-border integrated service platform to make cross-border trade easier. Company operates in Japan, Hong Kong and China, with maximum revenue from Japan.

About LPCN Lipocine Inc.

Lipocine Inc is a clinical-stage biopharmaceutical company that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates, or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy (TRT). It also has other products in the pipeline, such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.

Share on Social Networks: